Table 1.
Summary of chemiluminescent probes discussed in this review.
| |||||||
|---|---|---|---|---|---|---|---|
| Animal imaging | |||||||
| Probe |
λα
(nm) |
Analyte | Mice, Injection | Peak Brightness a | Trials | Time Course | Ref |
| Ratio-pHCL-1 | 530, 580 | PH | BALB-C, IP | 1x108 p s−1 cm−2 sr−1 | 3 | Single | [19] |
| CL-F | 540 | F− | BALB-C, back injection | Arbitrary units | 2 | Single | [20] |
| PCL | 450–470 | Pd2+ | Subcutaneous | 4.5x107 p s−1 cm−2 sr−1 | 3 | 35 min | [21] |
| SCL-2 | 450–470 | H2S | BALB-C, IP | 2.5x107 p s−1 cm−2 sr−1 | 3 | 60-min | [22] |
| SHCL | 540 | biothiols | Subcutaneous | 1.5x10s p s−1 cm−2 sr−1 | 3 | Single | [23] |
| HNOCL-1 | 525 | HNO | BALB-C, IP | 3.6x10s p s−1 cm−2 sr−1 | 1 | 30-min | [24] |
| HyCL-4-AM | 516 | Hypoxia in tumors | IM, IP | 10s p s−1 cm−2 sr−1 | 3–6 | 100-min | [25] |
| CL-N | 525 | HOCl | BALB-C, IP, IT | Signal/noise ratios | 1 | 60-min (IP) 80-min (IT) | [26] |
| HOCL-CL-510 | 520-540 | HOCl | Subcutaneous, IP, tibiotarsal joint | 10® p s−1 cm−2 sr−1 | 1 | 30-min (Sub) 21-min (IP) 12-min (TibJ) | [27] |
| HCCL-2 | 520-540 | HOCl | BALB-C, IP | 1.3x108 p s−1 cm−2 sr−1 | 3 | 10 min | [28] |
| H2O2-CL-510 | 520-540 | H2O2 | Live rat, brain ventricle | 105 p s−1 cm−2 sr−1 | 3 | 12 min | [30] |
| NCR1, NCR2 | 700 | O2•−, ONOO− | Live mice, IV | 13x106 p s−1 cm−2 sr−1 | 3 | 60-120 min | [31] |
| QM-B-CF | 600 | H2O2 | Live mice, IT | 5.6x105 p s−1 cm−2 sr−1 | 1 | 120-min | [32] |
| CL-SO | 700 | 1O2 | BALA-C, IP | 17500 cps | 2 | 12-min | [34] |
| ACLD | 620 | N2H4 | BALB-C, skin-pop | Arbitrary units | 1 | 80-min | [35] |
| CFR | 540 | O2•− | IV | 6x104 p s−1 cm−2 sr−1 | 3 | 120 min | [36] |
| MRPD | 540 | O2•− | IV | 4.8x104 p s−1 cm−2 sr−1 | 3 | 120 min | [37] |
| CFCL | 550 | FAP-α | BALB-C, IV, IT | 106 p s−1 cm−2 sr−1 | 1 | 60-min 110-min |
[38] |
| Probe 1 | 520–540 | Granzyme-B | IT | 1.5x107 p s−1 | 3 | - | [39] |
| NCPSG | >750 | β-galactosidase | IT | 104 p s−1 cm−2 sr−1 | 3 | 60-min | [40] |
| MSN@H6L@β-CD@AMPPD | 660 | Alkaline phosphatase | IV | 90 Arbitrary units | 5 | 60-min | [41] |
| Chemiluminescence microscopy | |||||||
| Probe |
λCL
(nm) |
Analyte | Cell Type | Instrumentation |
Acquisition time
(s) |
Ref | |
| H2O2-CL | 540 | H2O2 | Caco-2 | Olympus IX73 inverted microscope, EM-CCD camera | 5 | [29] | |
| NCR1, NCR2 | 700 | O2•−, ONOO− | HK2 | LX71 inverted microscope, infinity 3-1 (Lumenera) CCD camera | 10 | [31] | |
| NCPSG | >750 | β-galactosidase | SKOV3 | LX71 inverted microscope, infinity 3-1 (Lumenera) CCD camera | 60 | [40] | |
| Monitoring disease and infection | |||||||
| Probe |
λCL
(nm) |
Enzyme detected | Signal intensity | Ref | |||
| CLSP | 520–540 | Esterase–Salmonella | 1.6x107 RLU | [42] | |||
| CLLP | 520–540 | Phospholipase–Listeria Monocytogenesis | 1.0x106 RLU | [42] | |||
| CPCL | 540 | Carbapenemase–Imipenem-resistant Pseudomonas aeruginosa and Klebsiella pneumoniae | 40000 RLU | [43] | |||
| CCP | 470 | β-lactamase–E. Coli | 1000 LU | [44] | |||
| FLASH | 520–540 | Hip-1–Mycobacterium tuberculosis | 2.5x105 RLU | [45] | |||
| CLPSA | 520–540 | Prostate specific antigen–Human semen | ~20000 RLU | [46] | |||
| Ub-CL | 520–540 | Deubiquitinating enzymes | 180000 RLU | [47] | |||
Highest pixel intensity in image.